SecurityGRPOF / Tetra Bio-Pharma Inc. (39985Y102)
IndustryCannabis and Medical Marijuana Dispensaries
Institutional Owners0

Institutional Stock Ownership and Shareholders

Tetra Bio-Pharma Inc. (OTC:GRPOF) has 0 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Largest shareholders include .
Tetra Bio-Pharma Inc. (OTC:GRPOF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Prev Value
Current Value

Related News Stories

Tetra Bio-Pharma: A Quiet Company Getting Closer To Making Some Noise

2018-10-16 seekingalpha
Tetra Bio-Pharma is quietly bringing 3 drugs to market soon that show considerable promise in areas of underdeveloped research and servicing.

The CannaGuide: Complete Cannabis Coverage - Aphria Part 1 - Full Operations, Partnerships, And Investments Overview

2018-08-23 seekingalpha
Part 1 in the CannaGuide on Aphria covering the companies current operations, expansion plans, and strategic partnerships/investments. (92-7)

Neptune Technologies & Bioresources' (NEPT) CEO Jim Hamilton on Q1 2019 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Neptune Technologies & Bioresources, Inc. (NASDAQ:NEPT) Q1 2019 Earnings Conference Call August 15, 2018 8:00 AM ET (169-5)

CUSIP: 39985Y102